Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Obesity & Weight Loss Therapy received 2305 citations as per Google Scholar report
Suman Garlapati, PhD
Scientist
InvaGen Pharmaceuticals Inc
USA
Tel: 1-914-486-1898
Dr. Suman Garlapati, born and brought up at Khammam Dist, AP, India, Aug 6, 1981; BS in Biotech from Kakatiya University (2001), MS in Biotech, Bharathidasan University (2003), Ph.D. University. Mysore (2008), MBA in Production Management MKU (2010), Selected Post Doc Fellow from Oregon State University. Oregon, USA. Presently working as a Drug Safety & Pharmacovigilance Officer InvaGen Pharm, Inc (2009), Trained Pharmacovigilance specialist from i3 CanReg, Canada, Certified MedDRA Coder, USA– Recipient Prof. D.C. Cooper, Rajyapuraskar, Soc. Cytology & Genetics, Indian Govt. Executive council member of INC Res (Kendle, Inc). Anti-Retroviral Pregnancy Registry.
Obesity, Leptin gene disorders, Cancer Biology, Genetic Toxicology and Bioinformatics.
Useful Notes for the Obese: Bariatric Surgical Procedures
Suman Garlapati |
Editorial: J Obes Weight Loss Ther |
DOI: 10.4172/2165-7904.1000e106 |
Suman Garlapati |
Editorial: J Obes Weight Loss Ther |
DOI: 10.4172/2165-7904.1000e104 |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals